to join the discussion
4SI flat at 67c today but the real story is whether this tech play can hold its rand-hedge credentials if the USD/ZAR continues consolidating around 18.50 levels, because a strengthening rand squeezes the export arbitrage that makes local tech stocks interesting to offshore capit
4SI's 4.23% pullback to R68 warrants scrutiny against the broader tech selloff, particularly given how the JSE's technology cohort has been repriced on the back of rising real rates pushing up discount factors. Comparing to Datatec, which trades on materially higher enterprise mu
The 2.82% pop on 4SI today feels like consensus catching up to an already-priced narrative; what concerns me is whether the market has stress-tested the embedded value of their software contracts against a potential economic slowdown in SA corporate spend. Graham would ask what h
4SI's modest 1.43% gain today feels disconnected from the broader tech sector rotation we're seeing as EM risk-off pressures persist. With the rand weakening and foreign flows still hesitant, are local tech names like this pricing in enough margin of safety, or are valuations sti
4SI's decline to R66 appears overdone on a single-day basis; the real question is whether management can sustain mid-teens revenue growth while improving operating leverage, given the company's exposure to healthcare IT cycles and their historical difficulty scaling EBITDA margin
4SI up 1.45% to R70 today, and at these levels the tech play is looking more attractive than some of the bloated software peers trading at 25+ P/E multiples. Revenue growth trajectory here is solid enough to justify the valuation, especially if they can maintain margins through t
4SI's valuation at R69 looks stretched relative to Altron, which trades at a lower revenue multiple despite superior margins and diversified revenue streams across software and ICT services. The tech sector's current rotation toward profitability metrics should pressure 4SI unles
Trimmed my 4SI position at R69 because the balance sheet deterioration and capital intensity of their software transition don't justify the current valuation, even if the SaaS pivot eventually works out.